Assyro AI
US FDAUnited StatesCRLComplete Response Letter

Complete Response Letter NDA 505b1 219045 (Oct 21, 2024)

Issued October 21, 2024

Issued

October 21, 2024

Application

NDA 505b1 • 219045

Review center

CDER

Stage

Final Decision

Letter type

Complete Response Letter

Response due October 21, 2025Requires resubmission addressing deficiencies.

Document viewer

Read the FDA letter and send context to the co-pilot at any time.

Loading PDF…